CN117279897A - 抗菌化合物 - Google Patents
抗菌化合物 Download PDFInfo
- Publication number
- CN117279897A CN117279897A CN202280027718.2A CN202280027718A CN117279897A CN 117279897 A CN117279897 A CN 117279897A CN 202280027718 A CN202280027718 A CN 202280027718A CN 117279897 A CN117279897 A CN 117279897A
- Authority
- CN
- China
- Prior art keywords
- group
- alkyl
- substituted
- cycloalkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163148261P | 2021-02-11 | 2021-02-11 | |
| US63/148,261 | 2021-02-11 | ||
| PCT/US2022/015682 WO2022173758A1 (en) | 2021-02-11 | 2022-02-08 | Antibacterial compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117279897A true CN117279897A (zh) | 2023-12-22 |
Family
ID=82837229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280027718.2A Pending CN117279897A (zh) | 2021-02-11 | 2022-02-08 | 抗菌化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240166609A1 (https=) |
| EP (1) | EP4291550A4 (https=) |
| JP (1) | JP2024507139A (https=) |
| CN (1) | CN117279897A (https=) |
| AR (1) | AR124841A1 (https=) |
| TW (1) | TW202246218A (https=) |
| WO (1) | WO2022173758A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019345150A1 (en) * | 2018-09-20 | 2021-05-13 | Blacksmith Medicines, Inc. | Antibacterial compounds |
| TW202322818A (zh) | 2021-09-28 | 2023-06-16 | 美商福吉醫療公司 | Lpxc抑制劑及其用途 |
| TW202417432A (zh) * | 2022-08-10 | 2024-05-01 | 美商布萊克史密斯醫藥公司 | 抗菌化合物 |
| WO2025174875A1 (en) * | 2024-02-13 | 2025-08-21 | Blacksmith Medicines, Inc. | Antibacterial compounds |
| WO2025174868A1 (en) * | 2024-02-13 | 2025-08-21 | Blacksmith Medicines, Inc. | Antibacterial compounds |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3180749B2 (ja) | 1997-12-26 | 2001-06-25 | ダイソー株式会社 | ３−ヒドロキシ−γ−ブチロラクトン誘導体の新規製法 |
| WO2008027466A1 (en) * | 2006-08-31 | 2008-03-06 | Schering Corporation | Hydantoin derivatives useful as antibacterial agents |
| JP6006609B2 (ja) * | 2011-10-19 | 2016-10-12 | 大正製薬株式会社 | 新規なヒドロキサム酸誘導体を含有する医薬 |
| WO2015085238A1 (en) * | 2013-12-05 | 2015-06-11 | The Regents Of The University Of California, A California Corporation | Inhibitors of lpxc |
| DK3233843T3 (da) * | 2014-12-16 | 2019-11-18 | Novartis Ag | Isoxazol-hydraxamsyreforbindelser som LPXC-hæmmere |
| WO2018208987A2 (en) * | 2017-05-10 | 2018-11-15 | Forge Therapeutics, Inc. | Antibacterial compounds |
| WO2018216822A1 (en) | 2017-05-25 | 2018-11-29 | Taisho Pharmaceutical Co., Ltd. | Novel imidazole derivatives |
| WO2020102572A1 (en) | 2018-11-14 | 2020-05-22 | Forge Therapeutics, Inc. | Antibacterial compounds |
| KR20210093884A (ko) * | 2018-11-21 | 2021-07-28 | 다이쇼 세이야꾸 가부시끼가이샤 | 신규 이미다졸 유도체 |
| AR124839A1 (es) * | 2021-02-11 | 2023-05-10 | Forge Therapeutics Inc | Compuestos antibacterianos |
-
2022
- 2022-02-08 EP EP22753215.7A patent/EP4291550A4/en active Pending
- 2022-02-08 CN CN202280027718.2A patent/CN117279897A/zh active Pending
- 2022-02-08 US US18/264,838 patent/US20240166609A1/en active Pending
- 2022-02-08 TW TW111104618A patent/TW202246218A/zh unknown
- 2022-02-08 WO PCT/US2022/015682 patent/WO2022173758A1/en not_active Ceased
- 2022-02-08 JP JP2023548567A patent/JP2024507139A/ja active Pending
- 2022-02-08 AR ARP220100257A patent/AR124841A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024507139A (ja) | 2024-02-16 |
| WO2022173758A1 (en) | 2022-08-18 |
| AR124841A1 (es) | 2023-05-10 |
| EP4291550A1 (en) | 2023-12-20 |
| US20240166609A1 (en) | 2024-05-23 |
| EP4291550A4 (en) | 2025-01-22 |
| TW202246218A (zh) | 2022-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN117279897A (zh) | 抗菌化合物 | |
| CN117279898A (zh) | 抗菌化合物 | |
| TWI843142B (zh) | 用作shp2抑制劑的化合物及其應用 | |
| AU2017294231A1 (en) | Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof | |
| TW201431865A (zh) | 硼酸衍生物及其治療用途 | |
| TW201524953A (zh) | 治療活性化合物及其使用方法（二） | |
| CN112074507B (zh) | 作为抗菌素的化合物 | |
| CN1829728A (zh) | 新颖化合物 | |
| JP2025526728A (ja) | 抗菌化合物 | |
| CN114874209B (zh) | 噁二唑瞬时受体电位通道抑制剂 | |
| CN111163774A (zh) | 细菌外排泵抑制剂 | |
| TW202417437A (zh) | 抗菌化合物 | |
| CN106458931A (zh) | 抗菌的喹唑啉‑4(3h)‑酮衍生物 | |
| CN112996505A (zh) | 新型咪唑衍生物 | |
| JP4879991B2 (ja) | 抗高コレステロール血症化合物 | |
| CN107709314A (zh) | 外排泵抑制剂及其治疗性用途 | |
| WO2015027963A1 (zh) | 芳环类衍生物、其药物组合物及其应用 | |
| JP2025510512A (ja) | Ｌｐａ受容体活性と関連する状態の処置のための化合物および組成物 | |
| HK40097877A (zh) | 抗菌化合物 | |
| HK40097874A (zh) | 抗菌化合物 | |
| HK40119559A (zh) | 用於治疗与lpa受体活性相关的病症的化合物和组合物 | |
| HK40070400A (en) | Oxadiazole transient receptor potential channel inhibitors | |
| WO2025174868A1 (en) | Antibacterial compounds | |
| HK40050145A (en) | Novel imidazole derivative | |
| HK40043214A (en) | Compound acting as antibiotics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40097877 Country of ref document: HK |